08048035996
Xbira 250 mg Tablet UK Wholesale – Sheffield | Competitive Prices | Phoenix Exim | Trusted Exporter

1. General Information

Xbira 250 mg Tablet is an anti-androgen/androgen-biosynthesis inhibitor containing Abiraterone Acetate 250 mg. It is primarily used as part of hormone-based treatment for advanced prostate cancer. Abiraterone reduces androgen production, including testosterone, which can contribute to the growth of prostate cancer cells.

Xbira should be used only under the supervision of an appropriately qualified healthcare professional.

2. Product Information

ProductXbira 250 mg Tablet
Active ingredientAbiraterone Acetate
Strength250 mg
Dosage formOral tablet
Therapeutic categoryOncology / Hormonal therapy
Drug classAndrogen biosynthesis inhibitor
Manufacturer/MarketerCipla Ltd.
Prescription statusPrescription medicine
Main indicationAdvanced/metastatic prostate cancer

The official Cipla prescribing information confirms Abiraterone Acetate IP 250 mg in the 250 mg tablet formulation.

3. Uses of Xbira 250 mg

Xbira is used in the treatment of certain forms of advanced or metastatic prostate cancer, including metastatic castration-resistant prostate cancer (mCRPC). Depending on the treatment setting, abiraterone may also be used for metastatic hormone-sensitive/castration-sensitive prostate cancer in combination with androgen-deprivation therapy and corticosteroid therapy.

The exact indication and combination therapy should be determined by the treating oncologist.

4. Benefits of Xbira 250 mg

Potential therapeutic benefits include:

  • Helps reduce androgen production in the body.
  • Can help slow the growth of androgen-dependent prostate cancer cells.
  • Used as part of systemic treatment for advanced/metastatic prostate cancer.
  • Provides an oral treatment option for eligible patients.
  • Can be incorporated into established hormone-based treatment regimens under medical supervision.

Important: These are therapeutic purposes, not a guarantee of individual treatment outcomes.

5. Side Effects of Xbira 250 mg

Abiraterone can cause side effects because CYP17 inhibition can alter steroid hormone production. Possible adverse effects include:

  • Increased blood pressure
  • Low potassium levels
  • Fluid retention or swelling
  • Abnormal liver-function tests
  • Fatigue or weakness
  • Joint or muscle discomfort
  • Anemia
  • Hot flushes
  • Gastrointestinal symptoms

More serious liver problems and cardiovascular/fluid-related complications can occur, so appropriate monitoring by a healthcare professional is important.

6. Common Side Effects

Some commonly reported effects associated with abiraterone treatment include:

  • Fatigue
  • Joint swelling or discomfort
  • Increased blood pressure
  • Low potassium
  • Fluid retention
  • Hot flushes
  • Diarrhea
  • Abnormal liver enzymes

The frequency and severity can vary according to the patient's condition and other medicines being used.

7. How to Use Xbira 250 mg

Xbira should be taken exactly as prescribed by the oncologist.

A key administration point is that abiraterone tablets are generally taken on an empty stomach. Food can substantially increase abiraterone exposure and may increase the risk of adverse effects. Product information describes administration at least 1 hour before or 2 hours after food.

Do not change the dose, discontinue treatment, or alter accompanying prednisone/prednisolone therapy without medical advice.

8. How Xbira Works

Abiraterone acetate is converted in the body to abiraterone. It inhibits CYP17 (17α-hydroxylase/C17,20-lyase), an enzyme involved in androgen biosynthesis.

This reduces androgen production in the testes, adrenal glands and prostate-tumor tissue. Since androgens can stimulate prostate cancer growth, reducing their production can help control the disease.

9. Safety Advice

  • Prescription use only: Use Xbira only under specialist medical supervision.
  • Do not take with food: Food can increase drug exposure significantly.
  • Liver monitoring: Liver function should be monitored as recommended by the treating physician.
  • Blood pressure: Blood pressure may require regular monitoring.
  • Potassium: Potassium levels should be monitored because abiraterone can cause hypokalemia.
  • Fluid retention: Report significant swelling, rapid weight gain or breathing difficulties.
  • Heart conditions: Tell the doctor about existing cardiovascular problems before treatment.
  • Pregnancy precautions: Abiraterone can cause fetal harm. Appropriate precautions are required when handling the medicine, particularly for pregnant individuals.
  • Drug interactions: Inform the doctor about all prescription medicines, OTC medicines and supplements being used.
  • Do not self-medicate: This is an oncology medicine and should not be started or stopped without professional guidance.

10. Frequently Asked Questions

Q1. What is Xbira 250 mg Tablet?
Xbira 250 mg is an abiraterone acetate tablet used as part of treatment for certain advanced or metastatic prostate cancers.

Q2. What is the active ingredient in Xbira 250 mg?
Each tablet contains Abiraterone Acetate 250 mg.

Q3. Is Xbira a chemotherapy medicine?
Xbira is a hormonal/androgen-biosynthesis inhibitor, rather than a conventional cytotoxic chemotherapy drug.

Q4. Should Xbira be taken with food?
No. Abiraterone tablets are generally taken on an empty stomach because food can significantly increase drug exposure.

Q5. Can Xbira be taken without a prescription?
No. It is a prescription oncology medicine and should be used under medical supervision.

Q6. Is Xbira used alone?
Treatment commonly involves combination therapy, and the appropriate regimen depends on the type and stage of prostate cancer. Prednisone or prednisolone may be prescribed with abiraterone in specific treatment settings.

Q7. Does Xbira cure prostate cancer?
It is used to control and manage certain advanced prostate cancers; whether it can achieve remission or long-term disease control depends on the individual patient's disease and treatment plan.

Q8. What should I do if I miss a dose?
Follow the instructions provided by the treating healthcare professional. Do not double the next dose unless specifically instructed.

11. Substitutes for Xbira 250 mg

Potential alternatives with the same active ingredient and strength include other brands of Abiraterone Acetate 250 mg, subject to availability and regulatory approval in the relevant market.

Examples may include:

  • Abiraterone Acetate 250 mg tablets
  • Abirapro 250 mg
  • Arabira 250 mg
  • Other locally approved generic abiraterone 250 mg products

A substitute should not be selected solely on brand name. The oncologist or pharmacist should confirm the active ingredient, strength, formulation, manufacturer and regulatory status before substitution. For example, Arabira 250 mg is listed as containing the same 250 mg abiraterone acetate strength.

12. SEO & B2B Keywords

For Phoenix Exim – Pharmaceutical Exporter from Nagpur, India, you can use keywords such as:

  1. Xbira 250 mg Tablet exporter from India
  2. Xbira 250 mg Tablet supplier India
  3. Xbira 250 mg Abiraterone Acetate supplier
  4. Abiraterone Acetate 250 mg exporter India
  5. Xbira 250 mg pharmaceutical exporter
  6. Xbira 250 mg oncology medicine supplier
  7. Xbira 250 mg prostate cancer medicine
  8. Abiraterone 250 mg tablets exporter
  9. Xbira 250 mg tablets wholesale supplier
  10. Xbira 250 mg medicine exporter from Nagpur
  11. Abiraterone Acetate supplier from Nagpur India
  12. Xbira 250 mg B2B pharmaceutical supplier
  13. Xbira 250 mg export supplier India
  14. Abiraterone prostate cancer medicine supplier
  15. Xbira 250 mg international pharmaceutical supplier
  16. Xbira 250 mg tablets supplier for USA
  17. Xbira 250 mg tablets supplier for UK
  18. Xbira 250 mg tablets supplier for Australia
  19. Xbira 250 mg tablets supplier for Singapore
  20. Xbira 250 mg tablets supplier for Canada
  21. Xbira 250 mg tablets supplier for South Korea
  22. Xbira 250 mg tablets supplier for UAE
  23. Abiraterone 250 mg exporter to USA
  24. Abiraterone 250 mg exporter to UK
  25. Abiraterone 250 mg exporter to Australia
  26. Abiraterone 250 mg exporter to Canada
  27. Abiraterone 250 mg exporter to UAE
  28. Indian oncology medicine exporter
  29. Pharmaceutical exporter from Nagpur India
  30. Trusted Indian pharmaceutical export supplier 

Aug 12th, 2026 3:15 PM

Keywords